Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy

Clinical trial NCT02516813 · COMPLETED

Trial details

NCT number: NCT02516813
Sponsor: EMD Serono Research & Development Institute, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2015-09-15
Primary completion: 2021-03-26
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.